From: Health-related quality of life and its risk factors in Chinese hereditary angioedema patients
N (%) or median [IQR] | |
---|---|
Total | 104 (100.0) |
C1-INH HAE diagnosis | |
Type 1 | 101 (97.1) |
Type 2 | 3 (2.9) |
Sex | |
Male | 47 (45.2) |
Female | 57 (54.8) |
Age (years) | |
18–30 | 27 (26.0) |
31–44 | 52 (50.0) |
≥ 45 | 25 (24.0) |
Age at symptom onset (years) | |
0–10 | 16 (15.4) |
11–20 | 54 (51.9) |
≥ 21 | 34 (32.7) |
Annual attack frequency (n = 75) | 3.0[0.8–6.0] |
Attacks in the 4 weeks before HRQoL measurement | |
Positive | 49 (47.1) |
Negative | 55 (52.9) |
Current skin edema | |
Positive | 81 (77.9) |
Negative | 23 (22.1) |
Current GI edema | |
Positive | 58 (55.8) |
Negative | 46 (44.2) |
Current laryngeal edema | |
Positive | 26 (25.0) |
Negative | 78 (75.0) |
Severity evaluation | |
Mild | 39 (37.5) |
Moderate | 20 (19.2) |
Severe | 45 (43.3) |
Disease control status | |
Completely controlled | 35 (33.6) |
Partly controlled | 55 (52.9) |
Not controlled | 14 (13.5) |
Long-term prophylaxis | |
Positive | 74 (71.2) |
Negative | 30 (28.8) |
Family history | |
Positive | 72 (69.2) |
Negative | 32 (30.8) |